Zydus Wellness Limited — Investor Meet, 15-11-2024: Analysts/Institutional Investor Meet/Con. Call Updates

1. Financial Performance: Zydus Wellness achieved consolidated net sales of INR 4,907 million, marking a year-on-year growth of 12.1%, driven by an 8.4% increase in volumes. The EBITDA rose by 16.7% to INR 196 million, while net profit soared by 254.2% to INR 209 million, with adjusted PAT growth at 154.2% after accounting for exceptional items. The gross margin improved by 261 bps year-on-year, indicating effective management of rising input costs through operational efficiencies and price adjustments.

2. Future Outlook and Growth Drivers: Management expressed confidence in continued strong demand across key segments despite urban challenges, with rural markets showing gradual recovery. Innovative product launches, including adult nutrition offerings and plant-based spreads, are expected to drive growth. The acquisition of Naturell India, a healthy snacking company, aims to enhance the nutrition segment and is anticipated to be EPS accretive in the following year.

3. Order Book and Operational Updates: The company reported strong performance in the Personal Care segment with 26% growth, largely attributed to the Nycil brand. The Food & Nutrition segment also performed well, with Complan and Nutralite demonstrating positive growth. The expansion into the adult nutrition space and the introduction of innovative products are key operational highlights.

4. Analyst Q&A Insights (Detailed):

- Revenue and Profitability: Analysts sought clarification on Complan's year-on-year revenue growth amid market corrections. Management indicated an expected category growth of 5% to 6% annually while aiming for faster growth through targeted initiatives.

- Market Position and Competitive Landscape: Zydus maintains strong market shares in various segments, with healthy traction in rural markets, even amidst urban slowdown. Key competitors remain a concern, but management feels secure given their leadership in multiple categories.

- Operational Challenges or Risks: Management acknowledged challenges posed by rising commodity prices but has navigated these effectively. The potential impact of food inflation and increasing palm oil prices are considerations for future growth.

- Capex and Capital Allocation: The focus remains on strategic acquisitions, with the Naturell deal enhancing their nutrition portfolio and anticipated to contribute positively from the outset.

- Strategic Priorities and Long-Term Vision: Management aims to align with evolving consumer preferences through ongoing innovation and expansion into promising segments like adult nutrition.

5. Market or Regulatory Updates: While no specific regulatory changes were mentioned, the conversation indicated a general concern regarding food inflation and its effects on the consumer market.

6. Strategic Focus Areas: Zydus Wellness emphasizes innovation and targeting emerging consumer needs while maintaining operational efficiencies. The management's tone reflects confidence in navigating current market challenges while leveraging growth opportunities.

7. Investor Insight: Given the strong financial performance and effective management strategies, Zydus Wellness appears to hold promising growth potential. Engagement in strategic acquisitions and maintaining leadership in its segments suggests favorable positioning. The observed performance supports a ‘buy’ stance, considering the company’s alignment with consumer demand trends and ongoing innovation.